HuGE Literature Finder
Records
1
-
8
Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans. Nature communications 2019 Dec 10 (1): 5735. Mitchell Khadijah A, Nichols Noah, Tang Wei, Walling Jennifer, Stevenson Holly, Pineda Marbin, Stefanescu Roxana, Edelman Daniel C, Girvin Andrew T, Zingone Adriana, Sinha Sanju, Bowman Elise, Rossi Emily L, Arauz Rony F, Jack Zhu Yuelin, Lack Justin, Weingartner Elizabeth, Waterfall Josh, Pine Sharon R, Simmons John, Meltzer Paul, Ryan Bríd |
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion. Genes, chromosomes & cancer 2018 Aug . Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu |
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis. EBioMedicine 2018 Feb . Karachaliou Niki, Chaib Imane, Cardona Andres Felipe, Berenguer Jordi, Bracht Jillian Wilhelmina Paulina, Yang Jie, Cai Xueting, Wang Zhigang, Hu Chunping, Drozdowskyj Ana, Servat Carles Codony, Servat Jordi Codony, Ito Masaoki, Attili Ilaria, Aldeguer Erika, Capitan Ana Gimenez, Rodriguez July, Rojas Leonardo, Viteri Santiago, Molina-Vila Miguel Angel, Ou Sai-Hong Ignatius, Okada Morihito, Mok Tony S, Bivona Trever G, Ono Mayumi, Cui Jean, Cajal Santiago Ramón Y, Cao Peng, Rosell Rafa |
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Aug JCO2017747576. Ramalingam Suresh S, Yang James C-H, Lee Chee Khoon, Kurata Takayasu, Kim Dong-Wan, John Thomas, Nogami Naoyuki, Ohe Yuichiro, Mann Helen, Rukazenkov Yuri, Ghiorghiu Serban, Stetson Daniel, Markovets Aleksandra, Barrett J Carl, Thress Kenneth S, Jänne Pasi |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients. Oncotarget 2016 Feb . Wu Shang-Gin, Liu Yi-Nan, Tsai Meng-Feng, Chang Yih-Leong, Yu Chong-Jen, Yang Pan-Chyr, Yang James Chih-Hsin, Wen Yueh-Feng, Shih Jin-Yu |
Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach. Cancer genetics 2015 Sep 208 (9): 441-7. Hagemann Ian S, O'Neill Patrick K, Erill Ivan, Pfeifer John |
MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013 May 8 (5): 574-81. Boland Jennifer M, Jang Jin Sung, Li Jun, Lee Adam M, Wampfler Jason A, Erickson-Johnson Michele R, Soares Ibere, Yang Ping, Jen Jin, Oliveira Andre M, Yi Eunhee |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: